In a DR report, experts have voiced concerns saying the reimbursement given to around 21,000 employees and their respective spouses in Denmark goes against the law and will deeply affect the healthcare system. As such, the Danish Medicines Agency has asked for an explanation from Novo Nordisk’s management.
Meanwhile, the Danish Society for General Medicine spokesperson Maria Krüger said the situation is already dire as doctors have complained that there is a long list of patients wanting a prescription for the slimming drug, rejecting alternative treatments. This already takes time away from other patients who may have serious health problems and in need of consultations. Maria added that, “This is the first time that we see that the opposite is the case. Patients come to us specifically requesting treatment with Wegovy. And when the medication can be prescribed solely on the basis of the patient’s BMI (body mass index), we are not really making a medical decision.” Two other pharma companies – Lundbeck and Leo Pharma – have informed DR that they do not provide reimbursements for medicine for their employees and their spouses.
